| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/20/1999 | EP0891769A1 Methods for making controlled release devices for pharmaceuticals |
| 01/20/1999 | EP0891768A2 Scleroglucans and cosmetic compositions containing them |
| 01/20/1999 | EP0891202A1 Adhesive compositions including polyvinylpyrrolidone, acrylic acid polymers, and polyamines |
| 01/20/1999 | EP0891190A2 Method for enhancing the solubility of substantially water-insoluble compounds |
| 01/20/1999 | EP0891186A1 Nasal administration of agents for treatment of delayed onset emesis |
| 01/20/1999 | EP0891184A1 Method for solubilising hydrophylic materials (e.g. proteins) in a hydrophobic solvent |
| 01/20/1999 | EP0891180A1 Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process |
| 01/20/1999 | EP0861069A4 Co-processing method for making a free-flowing compressible powder and tablet therefrom |
| 01/20/1999 | EP0855913A4 Iron dextran formulations |
| 01/20/1999 | EP0778775B1 Cosolvent parenteral formulation of tirilazad |
| 01/20/1999 | EP0774958B1 Vesicle formulation comprising non-ionic surfactant |
| 01/20/1999 | EP0759986B1 Diagnostics for cancers expressing tyrosine phosphorylated crkl protein |
| 01/20/1999 | EP0735853B1 W/o/w emulsions |
| 01/20/1999 | EP0689428B1 Enhanced circulation effector composition and method |
| 01/20/1999 | EP0688208B1 Sugar- and sodium-free effervescent tablets and granules and process for preparing same |
| 01/20/1999 | EP0655911B1 Ophthalmological preparation |
| 01/20/1999 | CN1205636A Injectable quinolone formulations |
| 01/20/1999 | CN1205631A Transdermal device for delivery of flurbiprofen |
| 01/20/1999 | CN1205630A Transdermal device for delivery of flurbiprofen |
| 01/20/1999 | CN1205629A Controlled release formulation for poorly soluble basic drugs |
| 01/20/1999 | CN1205628A Method and prepns. for stabilizing biological materials by drying methods without freezing |
| 01/20/1999 | CN1205627A Desensitising toothpaste |
| 01/20/1999 | CN1205623A Method for producing transdermal patches (DE) |
| 01/20/1999 | CN1205613A Hybrid matrix implants and explants |
| 01/20/1999 | CN1205333A Nonionic vitamin E derivatives and method for prepartion thereof, and polymeric amphiphilic vesicles made therefrom |
| 01/20/1999 | CN1205228A Burn and scald ointment |
| 01/20/1999 | CN1205223A Smelling medicine for prevention and treatment of cold and its prepn. method |
| 01/20/1999 | CN1205221A Balsam pear keeping-in-mouth tablet and its prepn. method |
| 01/20/1999 | CN1205217A Pure Chinese medicinal syrup preparation and its production tech. |
| 01/20/1999 | CN1205204A Method and formulation for orally administering bioactive agents to and through the peyers patch |
| 01/20/1999 | CN1205203A Novel transfusion preparation |
| 01/19/1999 | US5861506 Compostable and thermoplastic cellulose ether-2-hydroxycarboxylic acid esters and mixed esters |
| 01/19/1999 | US5861439 Method for enhanced electrotransport agent delivery |
| 01/19/1999 | US5861387 Treatment and prevention of breast and endometrial cancer, bone loss, and for treating endometriosis |
| 01/19/1999 | US5861386 Prevention of loss of bone mass or bone minerals |
| 01/19/1999 | US5861373 IGF-1 to improve the neural condition |
| 01/19/1999 | US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes |
| 01/19/1999 | US5861179 Treatment of epilepsy |
| 01/19/1999 | US5861177 Spherical pancreatin particles free from added binder, free of 30-50 micrometer diameter particles; retain activity, made by treating before solvents are removed |
| 01/19/1999 | US5861176 Mixing alkoxides of silicon, calcium and phosphorous with an acid and active material(antibiotics, growth factors or enzyme inhibitors) then gelation, aging and drying yields porous glass matrix for healing or repairing bone defects |
| 01/19/1999 | US5861175 Use of fluorocarbons for diagnosis and treatment of articular disorders |
| 01/19/1999 | US5861174 Temperature sensitive gel for sustained delivery of protein drugs |
| 01/19/1999 | US5861173 Sustained release tablets with press coating on core of gel |
| 01/19/1999 | US5861172 Pharmaceutical formulations of compacted granulates of β-lactam antibiotics |
| 01/19/1999 | US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto |
| 01/19/1999 | US5861170 Acetylsalicyclic acid-containing transdermal application system for antithrombotic therapy |
| 01/19/1999 | US5861169 Hard candy with tooth plaque-neutralizing effect comprising an ammonium salt |
| 01/19/1999 | US5861166 Delivery device providing beneficial agent stability |
| 01/19/1999 | US5861159 Controlled release of pharmaceutically active substances for immunotherapy |
| 01/19/1999 | US5861149 Methods for wound treatment |
| 01/19/1999 | US5861148 Ophthalmic compositions and process of using |
| 01/19/1999 | US5861141 Pharmaceutical formulations of cefaclor |
| 01/19/1999 | US5860950 Arthroscopic irrigation solution and method for inhibition of pain and inflammation |
| 01/19/1999 | CA2166855C Process for deactivating or destroying microorganisms |
| 01/19/1999 | CA2140874C Oral compositions |
| 01/19/1999 | CA2108455C Pharmaceutical compositions against gastric disorders |
| 01/18/1999 | CA2254411A1 Ticlopidine hcl formulations |
| 01/14/1999 | WO1999001579A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 01/14/1999 | WO1999001500A1 Particulate polymeric materials and their production |
| 01/14/1999 | WO1999001498A1 Conjugate of polyethylene glycol and chitosan |
| 01/14/1999 | WO1999001463A2 Modified glycosides, compositions comprised thereof and methods of use thereof |
| 01/14/1999 | WO1999001358A1 Milling bottle for autoclaving of pharmaceutical suspensions |
| 01/14/1999 | WO1999001213A1 Microbeads prepared from cross-linked polysaccharide hydrogel capable of containing molecules of biological interest or cells |
| 01/14/1999 | WO1999001169A1 Syringe and capsule therefor |
| 01/14/1999 | WO1999001156A1 Polylactic acid scleral plugs |
| 01/14/1999 | WO1999001143A1 Cross-linked polysaccharide drug carrier |
| 01/14/1999 | WO1999001138A1 A pharmaceutical formulation of uridine triphosphate suitable for administration in a small volume |
| 01/14/1999 | WO1999001137A1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 01/14/1999 | WO1999001135A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 01/14/1999 | WO1999001133A1 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 01/14/1999 | WO1999001129A1 Process for preparing controlled-release dihydropyridine compositions |
| 01/14/1999 | WO1999001123A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | WO1999001122A1 Delayed-release dosage forms of sertraline |
| 01/14/1999 | WO1999001121A1 Sertraline salts and sustained-release dosage forms of sertraline |
| 01/14/1999 | WO1999001120A1 Solubilized sertraline compositions |
| 01/14/1999 | WO1999001116A1 Transdermal therapeutic system (tts) for administering sexual steroid hormones |
| 01/14/1999 | WO1999001115A1 Colon selective drug delivery composition |
| 01/14/1999 | WO1999001114A1 Prolonged anesthesia in joints and body spaces |
| 01/14/1999 | WO1999001113A1 Gelatine encapsulated solution dosage forms of sertraline |
| 01/14/1999 | WO1999001112A1 Multiple unit effervescent dosage form |
| 01/14/1999 | WO1999001111A1 Stabilized sustained release tramadol formulations |
| 01/14/1999 | WO1999001110A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 01/14/1999 | WO1999001109A2 Therapeutical system for transdermal delivery of levonorgestrel |
| 01/14/1999 | WO1999001108A1 Quick release compositions |
| 01/14/1999 | WO1999001044A1 Palatable elemental medical food |
| 01/14/1999 | WO1999001033A1 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 01/14/1999 | WO1998051694A3 Hydrophilic, hydrophobic, and thermoreversible saccharide gels and foams, and methods for producing same |
| 01/14/1999 | WO1998034952A3 Il-2 gene expression and delivery systems and uses |
| 01/14/1999 | DE19730023A1 Hochreine Ciprofloxacin-Infusion High purity ciprofloxacin infusion |
| 01/14/1999 | DE19729879A1 Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin A storage stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 01/14/1999 | DE19729487A1 Verfahren zur Herstellung von Wirkstoff-Zubereitungen mit kontrollierter Freisetzung aus einer Matrix A process for producing active ingredient compositions with controlled release from a matrix |
| 01/14/1999 | DE19729305A1 Thermoplastische Mischung auf Basis von Stärke enthaltend mindestens eine kationische und mindestens eine anionische Stärke, Verfahren zu ihrer Herstellung sowie Verwendung Thermoplastic mixture based on starch containing at least one cationic and at least one anionic starch, process for their preparation and use |
| 01/14/1999 | CA2295720A1 Transdermal therapeutic system (tts) for administering sexual steroid hormones |
| 01/14/1999 | CA2294988A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 01/14/1999 | CA2294900A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 01/14/1999 | CA2294785A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | CA2294714A1 Polylactic acid scleral plugs |
| 01/14/1999 | CA2294267A1 Particulate polymeric materials and their production |
| 01/13/1999 | EP0890577A1 Composition comprising an aqueous dispersion of lipid vesicules, based on cholesteryl carbamates, cosmetic use and compounds |
| 01/13/1999 | EP0890362A1 Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy |